Principal Investigator

Nobuki Nakanishi, PhD

Dr. Nakanishi’s current research is focused on (1) the regulation of NMDA-type glutamate receptors and their roles in neurodegenerative diseases, such as Alzheimer’s Disease and stroke (2) the transcription factor MEF2 and its roles in autism spectrum disorders.

Prior to joining Scintillon, he was an Assistant Professor at Harvard Medical School, and an Associate Professor at the Sanford-Burnham-Prebys Medical Discovery Institute.